Sartorius Stedim (DIM) | Stock Overview & Key Data

What is DIM's 52-week high and low?

In the last 52 weeks, Sartorius Stedim reached a high of €224.00 (on January 6, 2026) and a low of €150.00 (on April 30, 2026).

What is the market cap and P/E ratio for DIM?

Curious about Sartorius Stedim's size and valuation? Its market capitalization stands at 15.79B. When it comes to valuation, the P/E ratio (trailing twelve months) is 59.45, and the forward P/E (looking ahead) is 26.24.

Does DIM pay dividends? If so, what's the yield?

Yes, Sartorius Stedim is a dividend-paying stock. Investors have recently enjoyed a trailing annual dividend yield of 0.35%, and the company has paid an average of €0.94 per share annually over the past 3 years.

Who are Sartorius Stedim's main competitors or similar companies to consider before investing?

When looking at Sartorius Stedim, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:

Company	Mkt Cap	Sector	Industry	1Y Return	3Y Return
EssilorLuxottica EL	88.12B	Healthcare	Medical Instruments & Supplies	-6.21%	-6.21%
Amplitude Surgical AMPLI	302.26M	Healthcare	Medical Instruments & Supplies	95.31%	105.59%
Crossject S.A ALCJ	105.59M	Healthcare	Medical Instruments & Supplies	6.04%	-50.89%
Visiomed Group SA ALVMG	52.83M	Healthcare	Medical Instruments & Supplies	0.00%	0.00%
Spineway S.A ALSPW	5.76M	Healthcare	Medical Instruments & Supplies	-25.00%	-25.00%

For a more comprehensive list, please see the Peer Performance Comparison table on this page.

What are the key financial health indicators for Sartorius Stedim Biotech S.A.? (e.g., ROE, Debt/Equity)

To get a sense of Sartorius Stedim's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is 6.59%, the Debt to Equity ratio from the most recent quarter is 63.11, and its Gross Profit Margin stands at 41.04%.

What is the recent revenue and earnings growth for DIM?

Looking at Sartorius Stedim's growth, its revenue over the trailing twelve months (TTM) was €3B. Compared to the same quarter last year (YoY), quarterly revenue grew by 2.30%, and quarterly earnings saw a YoY growth of 2.90%.

How much of DIM stock is held by insiders and institutions?

Wondering who owns Sartorius Stedim stock? Company insiders (like executives and directors) hold about 71.50% of the shares, while institutional investors (such as mutual funds and pension funds) own approximately 12.11%.

For more common questions about our data, please visit our About Data page.